It addresses the shortage of radiologists and pathologists and frees up doctors to deal with complex cases
Besides health, trade and IT/BPO sectors saw vacancies increasing during the pandemic's Omicron phase
Company founded by 4 IIT graduates will use money to expand its presence and for improving technology
First major acquisition by Aman Mehta after taking charge at Torrent Pharma in August
Taking legal advice on next steps to pursue open offer for 26% stake in Fortis
Some cities like Delhi and Mumbai are also witnessing cases of leptospirosis and gastroenteritis fevers
It will recommend 'legally enforceable mechanisms', is expected to give a report in 90 days
Vikas Nahar's enterprise does Rs 40 cr a month on average, selling exotic and local nuts processed at 16,000 sq ft of processing space that he now plans to scale up by another 100,000 sq ft
'They (the next 125 years) look more challenging than the past 125 years. The world has changed. We have to make quicker decisions'
PGFI's revenues for the year ended March 31, 2022, had stood at around Rs 498 crore while profit for the year was at 102.76 crore. But pre-Covid, turnover was in the region of Rs 535 crore
SSI Mantra has already been used for 22 complex procedures at Delhi hospital
What is Pashu Aadhaar and how to apply for it? Here's all you need to know
Drug maker Lupin on Tuesday said its biosimilar product Rymti, indicated for the treatment of arthritis, has received approval from the Canadian health authority. The company's product is the biosimilar of reference drug Enbrel (Etanercept). The product is indicated for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis , plaque psoriasis and paediatric plaque psoriasis. "The approval for Rymti in Canada is a key milestone in our endeavours to improve access to medicines," Lupin Biotech President Cyrus Karkaria said in a statement. It underscores the scientific success of the company's biosimilar programmes and commitment to advancing healthcare through innovation, he added.
Tata GoFit is available in two pack sizes of 500 grams and one kg, with 18 grams of protein per serving of 25 grams in two flavours--rich chocolate and cafe mocha
Will be critical to the success of India's drive to eliminate TB by 2025
Tomato Flu cases have surged in India, more than three months after its inception. Read this detailed article to understand Tomato Flu, its causes, symptoms, diagnosis and treatment
Regulator looking to cap prices of Sitagliptin, Linagliptin and combinations
An outpatient will be charged GST for medicines and consumables bought that were prescribed in the course of providing health care services
While the daily average Covid vaccination doses cross 2.8 million mark, over 880,000 special vaccination camps have been organised in the country
As part of that strategy, the SoftBank-backed firm is setting up the world's largest eyewear manufacturing plant in Bhiwadi, a city in Rajasthan